| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299069 Methods for treating hepatitis C |
| 12/27/2007 | US20070299068 viricides comprising (3-cyano-indol-2-yl)phenyl derivatives, used for for treating viral diseases and infections or for affecting viral internal ribosome entry site (IRES) activity |
| 12/27/2007 | US20070299041 Induction of innate immunity by vitamin d3 and its analogs |
| 12/27/2007 | US20070298470 Improving manufacture of clavulanic acid; DNA encoding genes essential for clavam-2-carboxylate (C2C), 2-hydroxymethylclavam (2HMC), or 2-(3-alanyl)clavam (AC) biosynthesis in S. clavuligerus which are not essential for clavulanic acid biosynthesis |
| 12/27/2007 | US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits |
| 12/27/2007 | US20070298118 Exosome transfer of nucleic acids to cells |
| 12/27/2007 | US20070298054 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation |
| 12/27/2007 | US20070298053 Cattle reproductive disease vaccines |
| 12/27/2007 | US20070298052 Drying Process for Presserving an Active Agent as a Higly Viscous Liquid |
| 12/27/2007 | US20070298051 Adjuvants Of Immune Response |
| 12/27/2007 | US20070298050 direct replacement of chloroplast Photosystem II (PSII) reaction center protein coding regions to achieve expression of recombinant protein above 5% of total protein; edible algae; mammary associated serum amyloid A3 (M-SAA3) |
| 12/27/2007 | US20070298048 Non-viral gene delivery system |
| 12/27/2007 | US20070298047 Recombinant antigens for diagnosis and prevention of murine typhus |
| 12/27/2007 | US20070298046 Identifying T-cells in a sample that become activated in the presence of an amino acid sequence of a peptide with the same function as a CD8 T cell epitope of a vaccinia or variola virus; diagnosing vaccinia or variola virus infection by determining if the T-cells are activated by the peptide |
| 12/27/2007 | US20070298043 Novel Antibacterial Agents and Methods of Identifying and Utilizing Same |
| 12/27/2007 | US20070298032 Proteins Involved In Quorum Sensing |
| 12/27/2007 | US20070298016 Methods For The Generation Of Hepatocyte-Like Cells From Human Blastocyst-Derived Stem (Hbs) |
| 12/27/2007 | US20070297982 Preparation And Composition Of Inter-Alpha Inhibitor Proteins From Human Plasma For Therapeutic Use |
| 12/27/2007 | DE102006029448A1 Pharmazeutische Zusammensetzung mit einem extrazellulären Polyanion aus Arthrospira A pharmaceutical composition comprising an extracellular polyanion from Arthrospira |
| 12/27/2007 | DE102006029074A1 4-Amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidin-Derivate, Verfahren zu ihrer Herstellung und deren Verwendung als antivirale Wirkstoffe 4-amino-3-arylamino-6-arylpyrazolo [3,4-d] pyrimidine derivatives, processes for their preparation and their use as antiviral agents |
| 12/27/2007 | DE102006028649A1 New 5-quinoline derivatives are topoisomerase inhibitors useful to treat bacterial infections |
| 12/27/2007 | CA2656034A1 Fused [d]pyridazin-7-ones |
| 12/27/2007 | CA2656017A1 Use of pyridone derivatives in the prevention and treatment of radiation-induced lung injuries |
| 12/27/2007 | CA2655403A1 Antibacterial benzothiazoles and thiazolopyridines |
| 12/27/2007 | CA2654884A1 Macrocyclic compounds as antiviral agents |
| 12/27/2007 | CA2653233A1 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 12/27/2007 | CA2652633A1 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof |
| 12/27/2007 | CA2652612A1 Inhibitors of akt (protein kinase b) |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870412A1 2-thioethenyl carbapenem derivative |
| 12/26/2007 | EP1870411A1 Process for the preparation and purification of valgancyclovir |
| 12/26/2007 | EP1870409A1 Benzimidazole compound |
| 12/26/2007 | EP1870109A1 Improved combined vaccine against mycoplasma hyopneumoniae and porcine viruses |
| 12/26/2007 | EP1869054A2 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv |
| 12/26/2007 | EP1869037A1 Heterobicylic inhibitors of hvc |
| 12/26/2007 | EP1869030A1 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| 12/26/2007 | EP1869029A1 An oxindole oxazolidinone as antibacterial agent |
| 12/26/2007 | EP1868636A2 Uses of recombinant super-compound interferons |
| 12/26/2007 | EP1868594A1 Ganglionic blocking agents for the treatment of epithelial diseases |
| 12/26/2007 | EP1868589A1 A process for the preparation of poly dl-lactide-co-glycolide nanoparticles having antitubercular drugs encapsulated therein |
| 12/26/2007 | EP1868581A1 Pharmaceutical compositions having improved dissolution profiles for poorly soluble drugs |
| 12/26/2007 | EP1868572A2 Administration of glutathione (reduced) via intravenous or encapsulated in liposome for treatment of tnf-alpha effects and elu-like viral symptoms |
| 12/26/2007 | EP1654036B1 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 12/26/2007 | EP1567137B1 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
| 12/26/2007 | EP1478770B1 Screening method for orthopoxvirus antivirals |
| 12/26/2007 | EP1333810B1 Oral dosage self-emulsifying formulations of pyranone protease inhibitors |
| 12/26/2007 | EP1287024B1 Virulence genes, proteins, and their use |
| 12/26/2007 | EP1235596B1 Use of lytic toxins and toxin conjugates |
| 12/26/2007 | EP1187835B1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof |
| 12/26/2007 | EP0996710B1 Component of bromelain |
| 12/26/2007 | EP0837630B1 Prodrugs of pharmaceuticals with improved bioavailability |
| 12/26/2007 | EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 12/26/2007 | CN101094687A Nutritional composition comprising indigestible oligosaccharides |
| 12/26/2007 | CN101092620A Structure and application of antisense oligonucleotide of anti influenza virus with target directional apoptosis induction factor |
| 12/26/2007 | CN101092609A Vaccine against mumps containing a JERYL-LYNN virus strain |
| 12/26/2007 | CN101092605A Mutant strain of Brucella bacterin with weak poison, constructing method, and application |
| 12/26/2007 | CN101092456A Gene engineering antibody of human source neutrality for anti virus H5N1 of bird flu |
| 12/26/2007 | CN101092375A Compound of amide diketone acid, preparation method and application |
| 12/26/2007 | CN101092342A Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds |
| 12/26/2007 | CN101091781A Plaster for treating mycotic infection, and preparation method |
| 12/26/2007 | CN101091771A Chinese traditional medicine for anti diseases in respiratory passage system and genital system |
| 12/26/2007 | CN101091761A Medicine for treating recurrent beriberi |
| 12/26/2007 | CN101091755A Medicine for treating tinea disease and skin disease, and preparation method |
| 12/26/2007 | CN101091722A Injection of hydrolyzed peptide of liver |
| 12/26/2007 | CN101091712A Application of 9 ¿C (2 ¿C hydroxyethoxy methyl) in preparing silkworm drug |
| 12/26/2007 | CN101091710A Application of 3 [(4 ¿C ((Z)[(2Z) ¿C 4 oxo 2 (phenylimino) ¿C 1, 3 ¿C thiazolidine 5 idene] methyl) phenoxy) methyl] benzoic acid in agent for restraining staphylococcal bacteria |
| 12/26/2007 | CN101091704A Method for preparing medicine dedicated for treating condyloma acuminatum |
| 12/26/2007 | CN101091690A Composition containing tioconazole in use for hair |
| 12/26/2007 | CN100357439C Modified pig propagation and respiratory syndrome virus ORF5 gene and use thereof |
| 12/26/2007 | CN100357324C Effectors of innate immunity |
| 12/26/2007 | CN100357321C Stimulative phagocytizing factor and coded gene and application |
| 12/26/2007 | CN100357317C Pegylated T20 polypeptide |
| 12/26/2007 | CN100357308C Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 12/26/2007 | CN100357306C Rosemary acid anhydride compound ,its preparation method and use for treatment and prevention of AIDS |
| 12/26/2007 | CN100357284C Compounds against influenza virus and their preparing process and application |
| 12/26/2007 | CN100357283C Methionyl aminopeptidase inhibitor |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100356962C Traditional Chinese medicine and western medicine compositions comprising biphenyldicarboxylate |
| 12/26/2007 | CN100356961C Synergistic medicinal composition for treating hepatitis |
| 12/26/2007 | CN100356949C Pure natural compound oral liquid of hawthorn fruit for fowl and livestock and its processing method |
| 12/26/2007 | CN100356946C Cappillary artemisia-cape jasmine-rhubarb soft capsule and its prepn process |
| 12/26/2007 | CN100356925C Clindamycin palmitate hydrochloride dispersion tablet and its preparation method |
| 12/26/2007 | CN100356921C New combination of Cefpirome Sulfate and preparation method |
| 12/26/2007 | CN100356910C Medicine composition for treating beriberi |
| 12/26/2007 | CN100356853C Antimicrobial agent |
| 12/25/2007 | US7312333 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
| 12/25/2007 | US7312311 Attaching substances to microorganisms |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312246 Inhibiting interaction of alpha-helical protein with another protein or binding site; inhibiting cellular invasion of HIV |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312212 Bactericides for infrections in man |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/25/2007 | US7312199 Green tea extract ; for use in foods and supplements |
| 12/25/2007 | US7312064 Expression vector for use as transformation and gene expression tool in genetic engineering; minimum plasmid-based system for the generation of infectious RNA viruses, preferably influenza viruses, from cloned DNA |